233 related articles for article (PubMed ID: 26087768)
1. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.
Ohlmeier C; Langner I; Hillebrand K; Schmedt N; Mikolajczyk R; Riedel O; Garbe E
BMC Public Health; 2015 Jun; 15():570. PubMed ID: 26087768
[TBL] [Abstract][Full Text] [Related]
2. Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry.
Ohlmeier C; Langner I; Garbe E; Riedel O
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):778-84. PubMed ID: 27061445
[TBL] [Abstract][Full Text] [Related]
3. Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry.
Langner I; Ohlmeier C; Zeeb H; Haug U; Riedel O
BMJ Open; 2019 Jul; 9(7):e028223. PubMed ID: 31270118
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
5. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of premature mortality among urban immigrants in Bremen, Germany: a retrospective register-based linkage study.
Makarova N; Brand T; Brünings-Kuppe C; Pohlabeln H; Luttmann S
BMJ Open; 2016 Mar; 6(3):e007875. PubMed ID: 27000782
[TBL] [Abstract][Full Text] [Related]
7. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
Becher H; Kostev K; Schröder-Bernhardi D
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and external validity of the German Health Risk Institute (HRI) Database.
Andersohn F; Walker J
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):106-9. PubMed ID: 26530279
[TBL] [Abstract][Full Text] [Related]
9. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
10. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
[TBL] [Abstract][Full Text] [Related]
11. Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.
Ohlmeier C; Mikolajczyk R; Frick J; Prütz F; Haverkamp W; Garbe E
Clin Res Cardiol; 2015 Aug; 104(8):688-96. PubMed ID: 25777937
[TBL] [Abstract][Full Text] [Related]
12. [State of health of populations residing in geothermal areas of Tuscany].
Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations.
Pigeot I; Ahrens W
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):215-23. PubMed ID: 18200610
[TBL] [Abstract][Full Text] [Related]
14. Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data.
Hense S; Schink T; Kreisel SH; Marcelon L; Simondon F; Tahden M; Garbe E
Neuroepidemiology; 2014; 43(3-4):244-52. PubMed ID: 25531827
[TBL] [Abstract][Full Text] [Related]
15. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
16. [Tobacco-attributable mortality in Germany and in the German Federal States - calculations with data from a microcensus and mortality statistics].
Mons U
Gesundheitswesen; 2011 Apr; 73(4):238-46. PubMed ID: 20549599
[TBL] [Abstract][Full Text] [Related]
17. [How "representative" are SHI (statutory health insurance) data? Demographic and social differences and similarities between an SHI-insured population, the population of Lower Saxony, and that of the Federal Republic of Germany using the example of the AOK in Lower Saxony].
Jaunzeme J; Eberhard S; Geyer S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):447-54. PubMed ID: 23334292
[TBL] [Abstract][Full Text] [Related]
18. Migration pattern and mortality of ethnic German migrants from the former Soviet Union: a cohort study in Germany.
Kaucher S; Deckert A; Becher H; Winkler V
BMJ Open; 2017 Dec; 7(12):e019213. PubMed ID: 29259065
[TBL] [Abstract][Full Text] [Related]
19. Hospital admission in children and adolescents with or without type 1 diabetes from Germany: An analysis of statutory health insurance data on 12 million subjects.
Bohn B; Schwandt A; Ihle P; Icks A; Rosenbauer J; Karges B; Holl RW
Pediatr Diabetes; 2018 Jun; 19(4):721-726. PubMed ID: 29226514
[TBL] [Abstract][Full Text] [Related]
20. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
